iiinova — where your digital self keeps evolving

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 21/07/2025

Thank you so much for this honor! Volunteering with @ascocancer.bsky.social has been a big joy in my career and happy to continue many future years of service!

120

Reposted by Dionisia Quiroga, DO, PhD, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 21/07/2025

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiSd

083

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Christine Hodgdon @christeeny513.bsky.social · 31/05/2025

Thanks to these wonderful running buddies @drgattimays.bsky.social & @quirogad.bsky.social & @oncoalert.bsky.social for making it all happen!!

061

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 31/05/2025

Perfect #ASCO25 morning - beautiful Chicago lakeside run with two amazing leaders in breast cancer care and advocacy 🏃‍♀️🙏🏽 @christeeny513.bsky.social @drgattimays.bsky.social @oncoalert.bsky.social @ascocancer.bsky.social

1124

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 02/05/2025

#ASCO25 is right around the corner! ✨With >40K registrants, how can you best stand out of the crowd and make meaningful connections during the conference?✨ Here are some tips for trainees & early-career oncologists: connection.asco.org/do/networkin... @ascocancer.bsky.social @ascopost.bsky.social

connection.asco.org

Networking at ASCO25: Strategies for Success

Dr. Dionisia Quiroga shares her tips for making the 2025 ASCO Annual Meeting a networking triumph for early-career oncology professionals.

010

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Christian Rolfo @christianrolfo.bsky.social · 25/04/2025

Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team! @OhioStateMedOnc @OSUCCC_James @OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social

064

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 23/04/2025

Honored and grateful for the opportunity to discuss 3 oral abstracts at #ASCO25 and represent #OSUCCC @osucccjames.bsky.social @osuwexmed.bsky.social #Immunotherapy @sitcancer.bsky.social #PIIO @ascocancer.bsky.social

094

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 16/04/2025

My hometown 🙏🏽 Vaccinations work; please protect yourself and others

000

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Christian Rolfo @christianrolfo.bsky.social · 10/04/2025

🚨We are hiring Medical Oncologists at @OhioStateMedOnc ! Check the QR code below for the available positions! 3 pathways: - Physician Scientist - Clinical Scholar - Clinical Excellence Send your applications @OSUCCC_James @OhioStateMed

022

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Mark Cuban @mcuban.bsky.social · 22/03/2025

From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA

708319768473

Reposted by Dionisia Quiroga, DO, PhD, FASCO

NPR @npr.org · 21/03/2025

Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.

npr.org

Trump wants to erase DEI. Researchers worry it will upend work on health disparity

Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.

29465102

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 18/03/2025

Deadline approaching! The #SITC Women in Cancer Immunotherapy Network Leadership Institute applications close March 24. Don’t miss your opportunity to participate in panel discussions and presentations from experienced female leaders. Learn more here: www.sitcancer.org/professional...

033

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Scott Delaney @scott-delaney.bsky.social · 21/02/2025

NIH indirects case update: Hearing ongoing now, and I'll try to live tweet some notable exchanges. Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides: (I'm paraphrasing here)

14347196

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 12/02/2025

Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j @drgattimays.bsky.social @veredstearns.bsky.social

033

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 08/02/2025

In Ohio during FY23 (2022-2023) this was the impact of NIH funding: $1.01 Billion in grants and contracts $2.05 Billion in economic support 13,061 jobs supported This reduction in NIH indirect will decimate research and limit health care advances www.unitedformedicalresearch.org/nih-in-your-...

unitedformedicalresearch.org

NIH In Your State - United For Medical Research

Select a state on the map to see the impact of NIH funding across America.

0123

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 03/02/2025

Dr. Quiroga, we're delighted to have you on the expert panel and look forward to your presentation on immunotherapy for late-stage breast cancer!

032

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 03/02/2025

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

13412

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 02/02/2025

📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th! A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits @sitcancer.bsky.social #LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social

021

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Christian Rolfo @christianrolfo.bsky.social · 01/02/2025

OSU SABCS meeting - 200 participants in attendance. Great turn out and awesome presentations by our amazing Breast Cancer team. Very proud of them 🙂👏 @OhioStateMedOnc @StoverLab @quirogad @CherianMathew30 Maggie Gatti-Myes and all team! #SABCS24 @OSUCCC_James @OhioStateMed

021

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 01/02/2025

Love working with this group of talented docs! (We are so in sync we color coordinated without planning it #ScarletandGrey) @osucccjames.bsky.social

010

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 23/01/2025

⏱️ The next cancer cure is on hold. ⁦‪@NIH‬⁩ grants invest in future science gains that pay back for our citizens at a rate of more than 2:1 in economic activity. We are losing the battle for discovery.

science.org

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring

Researchers facing

23418

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Christine Hodgdon @christeeny513.bsky.social · 14/01/2025

Excellent advocacy program with Living Beyond Breast Cancer (LBBC) specific to patients living with stage IV/metastatic disease! This program was the foundation for my advocacy work and you'll meet some pretty amazing peeps along the way as well ♥️ bit.ly/3tEqyP9

011

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 09/01/2025

Looking for your first faculty position? Or perhaps new start? THE Ohio State University Comprehensive Cancer Center (Columbus, OH) is hiring in several #MedOnc sections - GI, Thoracic, Breast, Neuroendocrine, cutaneous. #AcademicJobs #OSUCCC @osucccjames.bsky.social @christianrolfo.bsky.social

0148

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Florez Lab @florezlab.bsky.social · 03/01/2025

🚨 Attention oncologists & hematologists in Latin America! 🚨 Join this new Florez lab study on the implementation of exercise recommendations by physicians. Consider participating in the survey below and have your opinions heard! 💪🩺 #Oncology #Hematology #Exercise #LatinAmerica

165

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 06/01/2025

Thanks to @narjustflorezmd.bsky.social and the #HearHer project for this awesome gift! 🙏🏽 🚨Important reminder that people who experience cancer are NOT all the same A woman or man is not “too young” to get lung cancer, same as for breast, colon, etc

071

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 05/01/2025

Join us 2/1/25 at the Hilton Columbus at Easton @osucccjames.bsky.social Update from the #SABCS24 👋Experts from #TheJames @mskcancercenter.bsky.social #Emory will address the latest insights and practical guidance presented at #SABCS24. Register here 👉 ccme.osu.edu/continuing-m...

064

Reposted by Dionisia Quiroga, DO, PhD, FASCO

The OncoAlert Network 🚨 @oncoalert.bsky.social · 23/12/2024

The Phase Ib/II trial (NCT06026657) investigates the combination of naxitamab, an anti-GD2 monoclonal antibody, gemcitabine, and TGFβ-imprinted, IL-21 expanded NK cells in HER2-negative breast cancer. Report with @drgattimays.bsky.social ( @vjoncology.bsky.social )

bit.ly

Phase Ib/II trial of naxitamab, gemcitabine and TGFβi NKs in HER- breast cancer - VJOncology

Margaret Gatti-Mays, MD MPH, The Ohio State University, Columbus, OH, discusses a Phase Ib/II trial (NCT06026657) of naxitamab, an anti-GD2...

053

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Amy Beumer @amybeumer.bsky.social · 13/12/2024

One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.

042

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 14/12/2024

Was great to talk to @janicetnbcmets.bsky.social about this a couple days ago —> higher doses are not always better ✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge! #bcsm #SABCS24

0114

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Stacey Tinianov, MPH @coffeemommy.bsky.social · 13/12/2024

Wonderful to meet you and chat with this whole crew last night! #SABCS24 (And, after all that, I forgot to post last night @maryamlustberg.bsky.social 🤣)

162

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 11/12/2024

#EMBER3 results presented @sabcs.bsky.social #SABCS24 by @breastcancerdoc.bsky.social Main take aways: 1) Imlunestrant ⬆️ PFS > SOC in 1L, ESR1 mut, mER+ BC 2) Imlunestrant + abemaciclib ⬆️ PFS in 1L mER+ BC irrespective of ESR1 or PIK3CA mut 3) Imlunestrant ⬇️ CNS progression 4) OS immature #bcsm

144

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 13/12/2024

The best #BreastOnc team in the country in my opinion 🥰 @osuwexmed.bsky.social @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social Love where you work

293

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Margaret Gatti-Mays, MD MPH @drgattimays.bsky.social · 11/12/2024

Great Wednesday agenda today at #SABCS24 @sabcs.bsky.social with lots of presentations by #OSUCCC @osuwexmed.bsky.social faculty @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social

071

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 10/12/2024

Completely agree, we really need trial data to tell us what benefit we are providing here long term. Do we improve survival or eat through drugs faster? As many things, just because we CAN doesn't mean we SHOULD. #SABCS24 #bcsm @sabcs.bsky.social @oncoalert.bsky.social

193

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 10/12/2024

Our newest @osucccjames.bsky.social breast med onc is hitting the ground running! 👏🏽

020

Reposted by Dionisia Quiroga, DO, PhD, FASCO

Arya Roy @aryaroy.bsky.social · 10/12/2024

Planning your career after fellowship? Our article on ASCO connection explores the pros & cons of academia, community & hybrid practices! A practical guide to help fellows make informed decision! @matthewkurianmd.bsky.social Rajat Thawani!

152